v3.19.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 6,908,068 $ 8,222,119
Prepaid expenses and other current assets 97,576 238,040
Total current assets 7,005,644 8,460,159
Equipment, net 54,780 36,271
Total assets 7,060,424 8,496,430
Current liabilities    
Accounts payable 1,427,056 1,738,837
Accrued expenses and other current liabilities 722,447 1,330,746
Senior Secured Convertible Note at fair value - face value principal of $6,219,000 and $7,750,00 as of June 30, 2019 and December 31, 2018, respectively 6,790,096 7,903,000
Total liabilities 8,939,599 10,972,583
COMMITMENTS AND CONTINGENCIES (NOTE 9)
Stockholders' Equity (Deficit)    
Common stock, par value $0.001; 100,000,000 shares authorized, 34,139,220 and 27,142,979 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively 34,139 27,143
Additional paid-in capital 40,518,952 32,619,282
Accumulated deficit (44,251,062) (36,992,911)
Total PAVmed Inc. Stockholders' Equity (Deficit) (1,536,448) (2,314,641)
Noncontrolling interest (342,727) (161,512)
Total Stockholders' equity (deficit) (1,879,175) (2,476,153)
Total Liabilities and Stockholders' Equity (Deficit) 7,060,424 8,496,430
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock $ 2,161,523 $ 2,031,845

Source